Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.
- DOI
- 10.1038/s41467-025-66747-z
- Published
- 2025 Dec 4
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-025-66747-z,
title = {Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.},
author = {Vaz-Salgado MÁ and Del Barco S and Sepúlveda JM and Alonso M and Pineda E and Balana C and Martínez-García M and Gironés R},
year = {2025},
journal = {Nature communications},
doi = {10.1038/s41467-025-66747-z},
url = {https://doi.org/10.1038/s41467-025-66747-z}
}RIS
TY - JOUR TI - Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial. AU - Vaz-Salgado MÁ AU - Del Barco S AU - Sepúlveda JM AU - Alonso M AU - Pineda E AU - Balana C AU - Martínez-García M AU - Gironés R PY - 2025 JO - Nature communications DO - 10.1038/s41467-025-66747-z UR - https://doi.org/10.1038/s41467-025-66747-z ER -
APA
MÁ, V., S, D. B., JM, S., M, A., E, P., C, B., M, M., & R, G. (2025). Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.. Nature communications. https://doi.org/10.1038/s41467-025-66747-z
Source records
- pubmed · retrieved 2026-09-27T06:22:56.122Z